Cargando…
The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: adding albuminuria to the SCORE scale increases the prevalence of very high/high cardiovascular risk among patients with chronic kidney disease
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155243/ https://www.ncbi.nlm.nih.gov/pubmed/35664262 http://dx.doi.org/10.1093/ckj/sfac019 |
_version_ | 1784718202328055808 |
---|---|
author | Cebrian, Ana Escobar, Carlos Aranda, Unai Palacios, Beatriz Capel, Margarita Sicras, Antoni Sicras, Aram Hormigo, Antonio Manito, Nicolás Botana, Manuel Alcázar, Roberto |
author_facet | Cebrian, Ana Escobar, Carlos Aranda, Unai Palacios, Beatriz Capel, Margarita Sicras, Antoni Sicras, Aram Hormigo, Antonio Manito, Nicolás Botana, Manuel Alcázar, Roberto |
author_sort | Cebrian, Ana |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9155243 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-91552432022-06-04 The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: adding albuminuria to the SCORE scale increases the prevalence of very high/high cardiovascular risk among patients with chronic kidney disease Cebrian, Ana Escobar, Carlos Aranda, Unai Palacios, Beatriz Capel, Margarita Sicras, Antoni Sicras, Aram Hormigo, Antonio Manito, Nicolás Botana, Manuel Alcázar, Roberto Clin Kidney J Letter to the Editor Oxford University Press 2022-02-10 /pmc/articles/PMC9155243/ /pubmed/35664262 http://dx.doi.org/10.1093/ckj/sfac019 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the ERA. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Letter to the Editor Cebrian, Ana Escobar, Carlos Aranda, Unai Palacios, Beatriz Capel, Margarita Sicras, Antoni Sicras, Aram Hormigo, Antonio Manito, Nicolás Botana, Manuel Alcázar, Roberto The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: adding albuminuria to the SCORE scale increases the prevalence of very high/high cardiovascular risk among patients with chronic kidney disease |
title | The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: adding albuminuria to the SCORE scale increases the prevalence of very high/high cardiovascular risk among patients with chronic kidney disease |
title_full | The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: adding albuminuria to the SCORE scale increases the prevalence of very high/high cardiovascular risk among patients with chronic kidney disease |
title_fullStr | The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: adding albuminuria to the SCORE scale increases the prevalence of very high/high cardiovascular risk among patients with chronic kidney disease |
title_full_unstemmed | The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: adding albuminuria to the SCORE scale increases the prevalence of very high/high cardiovascular risk among patients with chronic kidney disease |
title_short | The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: adding albuminuria to the SCORE scale increases the prevalence of very high/high cardiovascular risk among patients with chronic kidney disease |
title_sort | 2021 european society of cardiology cardiovascular disease prevention guidelines: adding albuminuria to the score scale increases the prevalence of very high/high cardiovascular risk among patients with chronic kidney disease |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155243/ https://www.ncbi.nlm.nih.gov/pubmed/35664262 http://dx.doi.org/10.1093/ckj/sfac019 |
work_keys_str_mv | AT cebrianana the2021europeansocietyofcardiologycardiovasculardiseasepreventionguidelinesaddingalbuminuriatothescorescaleincreasestheprevalenceofveryhighhighcardiovascularriskamongpatientswithchronickidneydisease AT escobarcarlos the2021europeansocietyofcardiologycardiovasculardiseasepreventionguidelinesaddingalbuminuriatothescorescaleincreasestheprevalenceofveryhighhighcardiovascularriskamongpatientswithchronickidneydisease AT arandaunai the2021europeansocietyofcardiologycardiovasculardiseasepreventionguidelinesaddingalbuminuriatothescorescaleincreasestheprevalenceofveryhighhighcardiovascularriskamongpatientswithchronickidneydisease AT palaciosbeatriz the2021europeansocietyofcardiologycardiovasculardiseasepreventionguidelinesaddingalbuminuriatothescorescaleincreasestheprevalenceofveryhighhighcardiovascularriskamongpatientswithchronickidneydisease AT capelmargarita the2021europeansocietyofcardiologycardiovasculardiseasepreventionguidelinesaddingalbuminuriatothescorescaleincreasestheprevalenceofveryhighhighcardiovascularriskamongpatientswithchronickidneydisease AT sicrasantoni the2021europeansocietyofcardiologycardiovasculardiseasepreventionguidelinesaddingalbuminuriatothescorescaleincreasestheprevalenceofveryhighhighcardiovascularriskamongpatientswithchronickidneydisease AT sicrasaram the2021europeansocietyofcardiologycardiovasculardiseasepreventionguidelinesaddingalbuminuriatothescorescaleincreasestheprevalenceofveryhighhighcardiovascularriskamongpatientswithchronickidneydisease AT hormigoantonio the2021europeansocietyofcardiologycardiovasculardiseasepreventionguidelinesaddingalbuminuriatothescorescaleincreasestheprevalenceofveryhighhighcardiovascularriskamongpatientswithchronickidneydisease AT manitonicolas the2021europeansocietyofcardiologycardiovasculardiseasepreventionguidelinesaddingalbuminuriatothescorescaleincreasestheprevalenceofveryhighhighcardiovascularriskamongpatientswithchronickidneydisease AT botanamanuel the2021europeansocietyofcardiologycardiovasculardiseasepreventionguidelinesaddingalbuminuriatothescorescaleincreasestheprevalenceofveryhighhighcardiovascularriskamongpatientswithchronickidneydisease AT alcazarroberto the2021europeansocietyofcardiologycardiovasculardiseasepreventionguidelinesaddingalbuminuriatothescorescaleincreasestheprevalenceofveryhighhighcardiovascularriskamongpatientswithchronickidneydisease AT cebrianana 2021europeansocietyofcardiologycardiovasculardiseasepreventionguidelinesaddingalbuminuriatothescorescaleincreasestheprevalenceofveryhighhighcardiovascularriskamongpatientswithchronickidneydisease AT escobarcarlos 2021europeansocietyofcardiologycardiovasculardiseasepreventionguidelinesaddingalbuminuriatothescorescaleincreasestheprevalenceofveryhighhighcardiovascularriskamongpatientswithchronickidneydisease AT arandaunai 2021europeansocietyofcardiologycardiovasculardiseasepreventionguidelinesaddingalbuminuriatothescorescaleincreasestheprevalenceofveryhighhighcardiovascularriskamongpatientswithchronickidneydisease AT palaciosbeatriz 2021europeansocietyofcardiologycardiovasculardiseasepreventionguidelinesaddingalbuminuriatothescorescaleincreasestheprevalenceofveryhighhighcardiovascularriskamongpatientswithchronickidneydisease AT capelmargarita 2021europeansocietyofcardiologycardiovasculardiseasepreventionguidelinesaddingalbuminuriatothescorescaleincreasestheprevalenceofveryhighhighcardiovascularriskamongpatientswithchronickidneydisease AT sicrasantoni 2021europeansocietyofcardiologycardiovasculardiseasepreventionguidelinesaddingalbuminuriatothescorescaleincreasestheprevalenceofveryhighhighcardiovascularriskamongpatientswithchronickidneydisease AT sicrasaram 2021europeansocietyofcardiologycardiovasculardiseasepreventionguidelinesaddingalbuminuriatothescorescaleincreasestheprevalenceofveryhighhighcardiovascularriskamongpatientswithchronickidneydisease AT hormigoantonio 2021europeansocietyofcardiologycardiovasculardiseasepreventionguidelinesaddingalbuminuriatothescorescaleincreasestheprevalenceofveryhighhighcardiovascularriskamongpatientswithchronickidneydisease AT manitonicolas 2021europeansocietyofcardiologycardiovasculardiseasepreventionguidelinesaddingalbuminuriatothescorescaleincreasestheprevalenceofveryhighhighcardiovascularriskamongpatientswithchronickidneydisease AT botanamanuel 2021europeansocietyofcardiologycardiovasculardiseasepreventionguidelinesaddingalbuminuriatothescorescaleincreasestheprevalenceofveryhighhighcardiovascularriskamongpatientswithchronickidneydisease AT alcazarroberto 2021europeansocietyofcardiologycardiovasculardiseasepreventionguidelinesaddingalbuminuriatothescorescaleincreasestheprevalenceofveryhighhighcardiovascularriskamongpatientswithchronickidneydisease |